University at Albany, State University of New York

Scholars Archive
Biological Sciences Faculty Scholarship

Biological Sciences

2018

Group II intron inhibits conjugative relaxase expression in bacteria
by mRNA targeting
Marlene Belfort
University at Albany, State University of New York

Dorie Smith
University at Albany, State University of New York

Carol Lyn Pizza
University at Albany, State University of New York

Guosheng Qu
University at Albany, State University of New York

The University at Albany community has made this article openly available.

Please share how this access benefits you.
Follow this and additional works at: https://scholarsarchive.library.albany.edu/biology_fac_scholar

Recommended Citation
Belfort, Marlene; Smith, Dorie; Pizza, Carol Lyn; and Qu, Guosheng, "Group II intron inhibits conjugative
relaxase expression in bacteria by mRNA targeting" (2018). Biological Sciences Faculty Scholarship. 18.
https://scholarsarchive.library.albany.edu/biology_fac_scholar/18

This work is licensed under a Creative Commons Attribution 4.0 International License.
This Article is brought to you for free and open access by the Biological Sciences at Scholars Archive. It has been
accepted for inclusion in Biological Sciences Faculty Scholarship by an authorized administrator of Scholars
Archive.
Please see Terms of Use. For more information, please contact scholarsarchive@albany.edu.

RESEARCH ARTICLE
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Abstract Group II introns are mobile ribozymes that are rare in bacterial genomes, often
cohabiting with various mobile elements, and seldom interrupting housekeeping genes. What
accounts for this distribution has not been well understood. Here, we demonstrate that Ll.LtrB, the
group II intron residing in a relaxase gene on a conjugative plasmid from Lactococcus lactis, inhibits
its host gene expression and restrains the naturally cohabiting mobile element from conjugative
horizontal transfer. We show that reduction in gene expression is mainly at the mRNA level, and
results from the interaction between exon-binding sequences (EBSs) in the intron and intronbinding sequences (IBSs) in the mRNA. The spliced intron targets the relaxase mRNA and reopens
ligated exons, causing major mRNA loss. Taken together, this study provides an explanation for the
distribution and paucity of group II introns in bacteria, and suggests a potential force for those
introns to evolve into spliceosomal introns.
DOI: https://doi.org/10.7554/eLife.34268.001
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Introduction
Introns interrupt genes in all domains of life. Group II introns, which are found in bacterial and organellar genomes, are ribozymes that self-splice from pre-mRNA transcripts independent of protein
catalysis (Lambowitz and Belfort, 2015; Lambowitz and Zimmerly, 2011; Zimmerly and Semper,
2015). Splicing of group II introns occurs by the same pathway as that of spliceosomal introns, of
which group II introns are the presumed ancestors (Lambowitz and Belfort, 2015; Novikova and
Belfort, 2017; Zimmerly and Semper, 2015). Group II introns are also mobile retroelements that
transpose into DNA via an RNA intermediate (Lambowitz and Zimmerly, 2011). Both splicing and
retromobility of group II introns in vivo require an intron-encoded protein (IEP) that is in complex
with the intron (Matsuura et al., 2001; Matsuura et al., 1997; Qu et al., 2016; Wank et al., 1999;
Zimmerly et al., 1995).
Group II introns have a highly conserved RNA structure consisting of six domains (Qu et al.,
2016; Robart et al., 2014; Toor et al., 2008). The largest domain, DI, contains the exon-binding
sequences (EBS), which interact through base pairing with the intron-binding sequences (IBS) in the
RNA exons or DNA homing target, to define the sites for splicing and retromobility of the intron,
respectively (Lambowitz and Zimmerly, 2011). DV is structurally the most conserved domain, which
contains the ‘catalytic triad’, nucleotide residues critical for catalysis (Qu et al., 2016; Robart et al.,
2014; Toor et al., 2008). DVI has a bulged adenosine, which is the nucleophile that initiates the
splicing reaction, yielding the branch-point of an intron lariat resulting from splicing. DIV often
accommodates an open reading frame (ORF) encoding the IEP, which is a reverse transcriptase (RT)
with maturase activity that facilitates intron splicing (Matsuura et al., 2001; Matsuura et al., 1997;
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eLife digest Proteins, the molecular workhorses of the cell, are encoded by genes within the
DNA. A given gene is often formed of several portions of coding DNA, the exons, which are
separated by sections of non-coding DNA called introns. When it is expressed, the entire gene,
including the introns, is ‘copied’ into a molecule of pre-messenger RNA (pre-mRNA). Enzymes then
remove the introns and stitch the exons together to produce a mature messenger RNA (mRNA) that
can serve as a template to create a protein. However, a particular type of intron, known as a group II
intron, can remove or ‘splice’ itself out of a pre-mRNA without the help of additional enzymes. Once
this is done, these introns can also insert themselves into DNA.
Scientists think that group II introns originated in bacteria, yet only about a quarter of bacterial
genomes sequenced so far contain this particular kind of intron. When these introns are present,
their numbers are low, and most of the time they are restricted to genes that are not required for
survival. It is not well understood why group II introns are so few and far between, and why they are
often not associated with essential genes in bacteria.
Qu et al. looked into a gene that contains a group II intron in the bacterium Lactococcus lactis,
and discovered that the expression of this gene was dramatically low. This decrease was due to
interactions between the group II intron and the exons within the mRNA. Once group II introns were
spliced out, they could target their mRNAs and reopen the junction where the exons had been
stitched together. These mRNAs were therefore lost, and the cell made less of the protein that the
gene encoded.
The findings by Qu et al. can help to explain why group II introns are so scarce, how they are
excluded from essential genes, and also how cells could use these sequences. In particular, group II
introns could have evolved to form the spliceosome, a complex structure that processes introns in
higher organisms. Finally, group II introns could be used in the laboratory to artificially silence genes
of interest.
DOI: https://doi.org/10.7554/eLife.34268.002

Wank et al., 1999; Zimmerly et al., 1995), and can promote retromobility of the intron in combination with the DNA endonuclease activity of the IEP (Matsuura et al., 1997; Qu et al., 2016;
Zimmerly et al., 1995).
Distribution of group II introns is different in bacteria and eukaryotes. Only about one quarter of
sequenced bacterial genomes contain group II introns and they are usually present in small numbers
within one genome. Moreover, they are mostly located in intergenic regions or non-conserved genes
that are rarely essential. In addition, bacterial group II introns frequently reside in various types of
mobile DNAs, which include pathogenicity islands and virulence plasmids (Candales et al., 2012;
Dai et al., 2003; Toro and Martı́nez-Abarca, 2013). This distribution suggests that bacterial group
II introns might be deleterious to host gene expression (Dai and Zimmerly, 2002a; Zimmerly and
Semper, 2015). In contrast, organellar introns are distributed more densely in mitochondrial and
chloroplast genomes, and are almost exclusively in essential housekeeping genes. In addition, group
II introns are absent in eukaryotic nuclear genomes although they are ancestrally closely related to
spliceosomal introns (Lambowitz and Belfort, 2015; Novikova and Belfort, 2017; Zimmerly and
Semper, 2015). Factors, including nucleus-cytosol compartmentalization, intracellular magnesium
concentrations, and interactions between the intron and spliced mRNA, have been conjectured to
be the evolutionary drivers for the evolution of group II introns into spliceosomal introns in eukaryotes (Martin and Koonin, 2006; Qu et al., 2014; Truong et al., 2015).
Here we investigated the impact of group II introns on their host gene expression in bacteria,
using Ll.LtrB, the group II intron that resides on a conjugative plasmid pRS01 and interrupts a relaxase host gene ltrB, in the bacterium Lactococcus lactis (Mills et al., 1996). We demonstrate that this
intron inhibits relaxase host gene expression and mobilization of the cohabiting conjugative element.
This group II intron-promoted inhibition results from RNA-RNA interactions between the spliced
intron and mRNA, reducing mRNA levels. These discoveries can explain the distribution of group II
introns in bacteria and provide yet another example of strict control and silencing of conjugation
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(Singh and Meijer, 2014; Zatyka and Thomas, 1998). These data also suggest a driving force for
the evolutionary transition of the group II introns to spliceosomal introns.

Results
A group II intron inhibits gene expression at the mRNA level
The group IIA Ll.LtrB intron interrupts the ltrB relaxase gene, which resides on the conjugative plasmid pRS01 and is required for pRS01 conjugative transmission (Belhocine et al., 2004;
Belhocine et al., 2005; Mills et al., 1996). Both intron-containing (Int+) and intron-less (Int-) ltrB
genes, under control of a nisin-inducible promoter on a pCY20 plasmid, were expressed in the native
host L. lactis strain IL1403 (Figure 1A). Northern blotting analysis of RNA (Figure 1B) indicated that
the relaxase mRNA abundance was much lower in the presence of the intron than in its absence
(21% vs. 100%). Consistent with the mRNA difference, the LtrB relaxase determined by Western
blotting also accumulated to lower levels in the Int+ cell (Figure 1C, 36% vs. 100%). Notably, a previous study showed an even larger (20-fold) difference in protein levels in Int- versus Int+ cells
(Chen et al., 2005). The dramatic decrease in the ltrB relaxase mRNA level in the presence of the
intron was confirmed by performing quantitative reverse transcription PCR (qRT-PCR). The difference in mRNA levels between the Int+ and the Int- cells was 23-fold (Figure 1D, Figure 1—source
data 1, Figure 1—figure supplement 1, 4.3% vs. 100%). The greater difference by qRT-PCR and
Northern blotting, may be accounted for by the different reference RNAs used (copA mRNA for
qRT-PCR vs. 16S rRNA for Northern blot) or by the inherent difference between the two techniques
in determining RNA levels.
By performing both reverse transcription and qRT-PCR analyses we determined that the decrease
in mRNA was not simply due to group II intron-promoted reduction in transcription rate (Figure 1—
figure supplement 1). We analyzed nascent ltrB primary transcripts in Int-/Int+ cells, utilizing a DNA
primer that bound 50 nucleotides downstream from the 50 -end of the transcript (Figure 1—figure
supplement 1A–B). Because of the proximity of the primer to the 50 -end, we presumed that the
yield of the cDNA or RT-PCR products generated was a reflection of transcription initiation, and
indeed there was only a 20% difference in the amount of cDNAs between Int- and Int+ (Figure 1—
figure supplements 1A, 100% vs. 79%; 1B, 100% vs. 74%). In addition, comparison of the relative
mRNA expression level in the Int- cell with that of total intron RNAs (pre-mRNA + Intron) in the Int+
cell, also indicated small transcription differences between Int-/Int+ cells (Figure 1—figure supplement 1C, primers, 1D, relative levels, 20.04 ± 2.00 vs. 25.65 ± 6.47).
In regard to splicing, we used Northern blotting, primer extension and qRT-PCR to determine the
relative abundance of the spliced intron. The data showed that the sum of intron-containing RNAs
(pre-mRNA + Intron) was relatively abundant, in contrast to the spliced mRNA (Figure 1B, Figure 1—
figure supplement 1D). Notably, a previous analysis of Ll.LtrB group II intron expression in the natural pRS01 context also showed that the ltrB mRNA level was much lower than that of the total intron
RNA (Chen et al., 2005). When the intron splicing efficiency was defined as the ratio of spliced
intron against the sum of the intron-containing RNAs (pre-mRNA + Intron), the numbers ranged
from 63% to 91% (Figure 1B, 91%; Figure 1—figure supplement 1D, 73.8%; Figure 1—figure supplement 2B, 63%). Thus, it does not appear that a splicing deficiency alone resulted in the mRNA
reduction.
Furthermore, we compared the decay rate of mRNAs expressed in Int-/Int+ cells. After a 30 min
induction of ltrB gene expression, the cells were treated with rifampicin to stop transcription, and
mRNA level was monitored over time and analyzed by Northern blotting (Figure 1—figure supplement 3A–B). Surprisingly, the decay rate of spliced mRNA for the Int+ cells was ¼ to ½ of the rate
for the mRNA of the Int- cells. Because the rates apply to a small residual fraction of the mRNA,
these results must be interpreted with caution. Nevertheless, they suggest that the reduction in
mRNA is not due to increased degradation.
We also investigated if gene expression was affected at the translation level. Comparison of
mRNA polysome profiling showed that there was only a marginal difference in mRNAs enriched in
the polysomal fractions between Int-/Int+ cells (Figure 1—figure supplement 4, 100% vs. 85%),
thereby rendering unlikely the possibility that the spliced mRNA experienced translational
repression.
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Figure 1. Inhibition of host gene expression by Ll.LtrB group II intron. (A) Diagram of the ltrB relaxase mRNA produced from full-length introncontaining pre-mRNA and intron-less constructs on the pCY20 plasmids (specR). The mRNA generated from splicing of the intron (red) (S-mRNA, left) is
compared to mRNA expressed from the intron-less construct (C-mRNA, right). (B) RNA analysis by Northern blotting using the mRNA splice-junction
and intron-specific probes. Representative data of three biological replicates is shown. Quantitation of mRNA (two bands, bracketed) and splicing,
Figure 1 continued on next page
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Figure 1 continued
normalized to 16S rRNA from the same blot after stripping and reprobing, is denoted at the bottom of the blot. The faint upper mRNA band may result
from an alternate transcription start site. Splicing efficiency is defined as the percentage of the spliced intron relative to the sum of pre-mRNA and
spliced intron. (C) LtrB relaxase protein levels determined by Western blotting. Representative data of three biological replicates is shown. Quantitation
of protein level, normalized to respective total protein levels, is denoted at the bottom of the blot. Portions of the coomassie stained gels before (left)
and after transfer (right) are shown below. (D) Representative qRT-PCR profile of expressed mRNAs in the Int- (blue) and Int+ (red) cells. PCR target and
primer pair are shown (top) and average relative mRNA levels in Int-/Int+(100% vs 4.3%) derived from mean Ct values of three biological replicates are
indicated.
DOI: https://doi.org/10.7554/eLife.34268.003
The following source data and figure supplements are available for figure 1:
Source data 1. RT-qPCR data for mRNA.
DOI: https://doi.org/10.7554/eLife.34268.008
Figure supplement 1. RNA analysis by qRT-PCR and reverse transcription.
DOI: https://doi.org/10.7554/eLife.34268.004
Figure supplement 2. Determination of splicing efficiency by reverse transcription analyses.
DOI: https://doi.org/10.7554/eLife.34268.005
Figure supplement 3. Intron may slow down interacting mRNA turnover.
DOI: https://doi.org/10.7554/eLife.34268.006
Figure supplement 4. Polysomal profiling.
DOI: https://doi.org/10.7554/eLife.34268.007

Additionally, although ltrB RNA levels can be condition-dependent (Chen et al., 2005), the differential expression levels between Int+ and Int- genes were not influenced by stressors and environmental changes, such as temperature, pH, salt and redox (data not shown). Taken together, we
concluded that the group II intron-promoted inhibition in gene expression is likely to be mainly at
the mRNA level.

Suppressing gene expression in bacteria is a common property of
group II introns
We also investigated if this substantial group II-intron mediated decrease in mRNA was independent
of plasmids and promoters from which the ltrB relaxase gene was expressed (Figure 2A). When the
Int-/Int+ ltrB genes were expressed from different plasmids, including pDL278 and pAMJ328, where
gene expression was driven by either constitutive or pH-inducible promoters, respectively, we
observed similar levels of mRNA reduction in the presence of the intron (pDL: 100% vs. 28%; pAMJ:
100% vs. 45%) (Figure 2A). This demonstrates that group II intron-promoted inhibition was independent of the plasmid and promoter from which the ltrB relaxase gene was expressed.
In addition, we extended this comparative study to other types of bacterial group II introns,
including a typical IIB intron, EcI5 (Dai and Zimmerly, 2002b) and a IIC intron, BhI1 (Candales et al.,
2012). The Int-/Int+ constructs of these introns were fused to an enhanced GFP reporter at the N-terminus. When expressed in Escherichia coli, levels of the mRNA dropped substantially for both EcI5
and BhI1 in the presence of the intron (Figure 2B,C). Also the GFP reporter was greatly reduced for
EcI5 with the intron present (Figure 2B bottom). Therefore, it appears that inhibiting gene expression in bacteria is a common property of group II introns.

Ll.LtrB intron reduces conjugation of pRS01
Because ltrB relaxase is required for initiation of plasmid conjugation (Belhocine et al., 2004;
Belhocine et al., 2005; Mills et al., 1996), and because ltrB gene expression is reduced in the presence of the intron, we wished to determine if the intron may inhibit conjugal transfer of pRS01. To
test this hypothesis, we measured conjugation frequency where the donor strain, IL1403, co-hosted
erythromycin resistant (ermR) conjugative plasmid pRS01 ltrB- (DLtrB::tet) and the pCY20 Int- or Int+
plasmid. After mating with fusidic acid-resistant (FAR) ILI403 the frequency of the ErmRFAR exconjugants was measured (Figure 3). Consistent with the LtrB relaxase protein levels (Figure 1C), the conjugation frequency of the Int+ donor was 3- to 4-fold lower that of the Int-, at 2.0 ± 0.1  10 4 versus
7.3 ± 10 4 exconjugants per donor (n = 2, p<0.05) (Figure 3 and data not shown). This result ties
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Figure 2. Reduction in gene expression persists with distinct plasmids, promoters, and group II introns. (A) RNA expression in Int-/Int+ cells under p23
promoter on the pDL278 plasmid (left) and under pH-inducible promoter on the pAMJ328 plasmid (right). RNAs in the Int-/Int+ cells were analyzed by
Northern blotting using probes specific for mRNA (top), intron RNA (middle) and 16S rRNA (bottom, loading control). Quantitation of mRNA and
splicing, normalized to 16S rRNA, is denoted at the bottom of image. Splicing efficiency is defined as the percentage of the spliced intron relative to
Figure 2 continued on next page
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Figure 2 continued
the sum of pre-mRNA and spliced intron. (B) EcI5 and (C) BhI1 group II introns cause reduced expression of mRNA. Group II intron-containing (EcI5+/
BhI1+) or the ligated exons (EcI5-/BhI1-) were fused to the coding sequence of GFP reporter. RNAs were analyzed by Northern blotting using probes
specific for mRNA (top), intron (middle), and 16S (bottom, loading control). Splicing efficiency is defined as the percentage of the spliced intron relative
to the sum of pre-mRNA and spliced intron. Splicing of both introns was at relatively low efficiency (EcI5: 17%; BhI1: 25%), which could be attributed to
an inherent property of these introns in E. coli, or to improper IEP protein folding. For EcI5, analysis of the HS-GFP protein on a coomassie stained 12%
SDS-polyacrylamide gel and relative protein levels are shown (B, bottom panel). TIR = Truncated Intron RNA. Biological replicates, n = 3. IPTG induced
(+) and uninduced (-) Int-/Int+ strains are shown.
DOI: https://doi.org/10.7554/eLife.34268.009

into a previous study (Novikova et al., 2014) suggesting that these two disparate mobile elements,

IL1403

IL1403
Spec R

pRS01

Intron -

R

X

LtrB::Tet

FA

pCY20

Erm R

donor

recipient

Intron +

R

X
μl

10

FA

5

(7.3 +/- 0.3) X 10 -4

Intron-

Int -

Intron+

Int + (2.0 +/- 0.1) X 10 -4

Figure 3. Inhibition of pRS01 conjugation by Ll.LtrB group II intron. Top, mating diagrams of IL1403 donor with
IL1403-FAR recipient. Donor cells contain pRS01 (ermR), with ltrB interrupted by a tet gene (red cross), coexpressed with Int- or Int+ (red bar) relaxase (brown and orange bars) from plasmid pCY20. Bottom, representative
conjugation result. Spotting of 10 and 5 ml of donor plus recipient conjugation mix (two replicates per donor) on
plates containing FA and Erm to select for transconjugants. Conjugation frequencies are shown (n = 2, p<0.05
based on two-tailed t-test with two-sample unequal variance).
DOI: https://doi.org/10.7554/eLife.34268.010
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the mobile intron and the conjugative pRS01 plasmid, have a functional interplay.

Spliced mRNA is associated with the intron
The first crystal structure of a group II intron lariat has revealed that ligated exons (mRNA) remain
bound to the spliced intron RNA (Robart et al., 2014). The recently determined cryo-electron
microscopy (cryo-EM) structure of the Ll.LtrB group II intron-IEP complex, that was isolated from its
native host, also shows that after splicing the mRNA is retained within the ribonucleoprotein (RNP)
(Qu et al., 2016). To confirm the presence of this intron-mRNA interaction in the bacterial cell, we
performed intron-RNA pull-down assays (Qu et al., 2014). Briefly, a streptavidin-specific RNA
aptamer was introduced into the Ll.LtrB intron in order to purify it over streptavidin resin
(Figure 4A). After purification, the intron and any associated RNAs, were isolated and analyzed by
reverse transcription. With the aptamer-containing intron, we observed that while the full-length
pre-mRNA and spliced intron were pulled down as expected, the small mRNA (smRNA), generated
from splicing of the aptamer-containing pre-mRNA with small exons (S-smRNA), was co-isolated.
However, the smRNA produced either from the Int- cell (C-smRNA) or from the aptamer-free Int+
cell (S-smRNA) were not co-isolated (Figure 4B). These results demonstrate that the intron is interacting with the spliced mRNA in the bacterial cell.

Intron-mRNA interaction inhibits gene expression
Next, we investigated the possibility that the intron-mRNA interaction might account for the group II
intron-promoted mRNA reduction. Similar to a previous study, we developed an in trans, two-plasmid expression system (Qu et al., 2014). We therefore co-expressed the intron-less ltrB relaxase
from the pCY20 plasmid with either the Ll.LtrB intron-containing (with flanking small exons), or
intron-less (small exons only) second plasmid, pLNRK (Figure 5A, left). Northern blotting analysis
again showed that the level of relaxase mRNA dramatically dropped in the presence of the intron
(21% vs. 100%). Additionally, an unexpected band smaller than the mRNA was detected (we call this
band RNA 3, see below) (Figure 5A, right). Also, Western blotting indicated less accumulation of
LtrB relaxase protein (24% vs. 100%).
It was necessary to elucidate if mRNA loss in this case is due to retrohoming or RNA-RNA interaction alone. To this end, mutants of the intron’s IEP, LtrA, in which retrohoming was stopped due to
inactivation of either the reverse transcriptase (RT) or DNA endonuclease (EN), were created (Figure 5—figure supplement 1A). RNA analysis showed that strong mRNA inhibition still persisted in
these mutants (Figure 5—figure supplement 1B), thus indicating that the inhibition of gene expression was due to the proposed RNA-RNA interaction rather than retrohoming.
Using the trans-expression system, we validated that the intron-mRNA interaction requires EBSIBS base-pairing, as shown previously in yeast (Qu et al., 2014). Mutants with nucleotide substitutions either in the IBS of the relaxase mRNA, or in the EBS in the intron expressed in trans, were
compared to the respective wild-type counterparts (Figure 5B,C). The results showed that the relaxase mRNA level was recovered in the EBS mutant strain (Figure 5C, 21% to 92%), and increased ~2fold in the IBS mutant (Figure 5D, 24% to 45%). Similar results were obtained with a different set of
IBS-EBS mutants (m*), with recovery of mRNA levels in the EBS and IBS mutants from 23% to 116%
and 23% to 51% respectively (Figure 5—figure supplement 2). Importantly, relaxase mRNA level
was again reduced when the IBS mutation in the mRNA complemented the mutated EBS from the
intron in the cell (Figure 5—figure supplement 2, down to 18%).

The spliced intron retargets the mRNA
The observation that splicing ability of the intron is required for mRNA inhibition (data not shown)
raised the possibility that the intron interaction with mRNA enables biochemical reactivity. We were
also curious about the unexpected bands (RNAs 3 and 4) observed in Figure 5C and D respectively.
Biochemical reactivity was validated and the origin of the extraneous bands was examined with the
in trans system through a series of Northern blotting assays with multiple probes and confirmed by
Rapid Amplification of cDNA Ends (RACE), which generates a cDNA copy for sequencing of the
desired RNA. Four RNA molecules (RNA 1-RNA 4) with identity clearly distinct from the RNAs that
were predicted to be expressed, were revealed (Figure 6A–C, Figure 6—figure supplement 1A–D,
Figure 6—figure supplement 2).
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Pre-mRNA (68 nt)
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(41 nt)
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B
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Figure 4. RNA-RNA interaction between intron and mRNA. (A) Schematic of construct harboring RNA aptamer.
Pre-mRNA bears the Ll.LtrB intron (red line), which is flanked by small exons (brown and orange boxes). The RNA
streptavidin aptamer (SA) is shown as a green stem-loop. Splicing of the aptamer-containing (Int+SA+) or aptamerless (Int+SA-) pre-mRNA produces small ligated exons (S-smRNA) that have the same sequence as the control
small mRNA (C-smRNA) generated from the intron-less construct (Int-). Primers IDT5078 and IDT1073 were used
for analysis of smRNAs and intron RNAs (pre-mRNA and spliced intron), respectively, in panel below and are
indicated as arrows. (B) mRNA binds to the intron (representative result of three biological replicates). RNAs with
the SA aptamer were purified using streptavidin resin and were detected by reverse transcription using 50 - 32PFigure 4 continued on next page
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Figure 4 continued
labeled primers specific for smRNAs and intron RNAs (pre-mRNA and Intron). The cDNA products were resolved
on an 8% urea-polyacrylamide gel. Cellular 6S non-coding RNA was used as a loading control. F, flow-through;
W4, the fourth wash; W8, the eighth wash, B, resin-bound.
DOI: https://doi.org/10.7554/eLife.34268.011

Among the four RNA molecules, two of them appeared in the intron-specific probing (Figure 6A;
Figure 6—figure supplement 1A, lane 7). The larger of the two, termed RNA 1, was also revealed
with both relaxase mRNA 50 - and 30 -exon probes (Figure 6B–C; Figure 6—figure supplement 1C–
D, lane 7), and was identified as the intron-containing relaxase pre-mRNA. This was confirmed by
probing a splicing-inactive catalytic triad mutant (T), which produced only this pre-mRNA band, RNA
1, and not RNAs 2–4 (Figure 6—figure supplement 1A,C,D, lane 3), and also by 50 -RACE followed
by PCR amplification and sequencing of the cDNA (Figure 6—figure supplement 2A). This result
suggests that the intron expressed in trans, is reverse splicing into the relaxase mRNA (Figure 6A).
The smaller of the two intron-specific RNAs, termed RNA 2, was also revealed with the probe for 30 exon but was absent in the probing for the 50 -exon (Figure 6B–C; Figure 6—figure supplement
1C–D, lane 7). With selective Northern blotting, along with 50 -RACE followed by cDNA sequencing,
this RNA was identified as the unspliced intron expressed in trans, with its small 30 -exon replaced by
the full-length 30 -exon of the relaxase mRNA (Figure 6A–B, Figure 6—figure supplement 1A,D,
Figure 6—figure supplement 2A). This result suggests that there was shuffling of exons or RNA
recombination, possibly between two reverse splicing reactions, that resulted in the formation of a
chimeric precursor (Figure 6B).
The third RNA, RNA 3, previously seen in Figure 5, was observed in both the exon splice junction
(Figure 6—figure supplement 1B, lane 7) and the relaxase mRNA 30 -exon-specific probings
(Figure 6B; Figure 6—figure supplement 1D, lane 7), but it was absent from the probing for 50 exon of the relaxase (Figure 6C; Figure 6—figure supplement 1C, lane 7). This RNA was further
defined by 50 -RACE followed by cDNA sequencing as a ligation product of the small 50 -exon
expressed in trans and the 30 -exon of the ltrB relaxase mRNA (Figure 6—figure supplement 2A).
Identification of RNA 3 suggested that RNA 2, the chimeric intron precursor resulting from reverse
splicing and RNA recombination described above, could be subject to forward splicing in the cell
(Figure 6B). This result is in accord with splicing being favored over reverse splicing in vivo. Notably,
RNA 3 appeared much more abundant than the relaxase mRNA (Figure 6B; Figure 6—figure supplement 1B,D).
Besides reverse splicing and its related RNA recombination, these experiments also suggested
the occurrence of a spliced exons reopening (SER) reaction (Jarrell et al., 1988) (Figure 6C). This
was evidenced by identification of the fourth RNA product, RNA 4, a free 50 -exon of the relaxase
mRNA. RNA 4 was observed in the probing specific for the 50 -exon of the relaxase mRNA
(Figure 6C; Figure 6—figure supplement 1C, lane 7) but was absent with all other probes
(Figure 6A–B; Figure 6—figure supplement 1A,B,D, lane 7). Additionally, its presence was validated by 30 -RACE analysis followed by PCR amplification and sequencing of the cDNA products
(Figure 6—figure supplement 2B). However, free 30 -exon of the relaxase mRNA, which should be
produced simultaneously with the free 50 -exon from the SER reaction, was not detected either by
Northern blotting or 30 -RACE (Figure 6B; Figure 6—figure supplement 1D, lane 7; Figure 6—figure supplement 2B). This could be attributed to bacterial mRNAs usually having a triphosphate at
the 50 end that is more resistant to mRNA decay than monophosphate (Celesnik et al., 2007;
Schoenberg, 2007). Notably, this free 50 -exon RNA was also revealed when the intron was
expressed in cis (Figure 6C; Figure 6—figure supplement 1C, lane 2; Figure 6—figure supplement
2B). Thus, these results suggest the SER, followed by RNA decay of the opened 30 -exon, to be a
mechanism resulting in mRNA loss in the cell.
To further elucidate how these retargeting reactions are responsible for mRNA disappearance,
we sought to examine mutants that were already created for this study. Initially we chose to identify
the four RNA molecules in the intron_EBSm* and mRNA_IBSm* mutants (Figure 5—figure supplement 2). Using the in trans system, Northern blotting analyses showed that none of the four RNA
products 1–4, that appeared with the wild-type strain existed in the mutants (Figure 7, lanes 3,5
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Figure 5. Intron-mRNA interaction causes mRNA inhibition. (A) Intron in trans expression system. In the schematic, ltrB relaxase mRNA (brown and
orange bars), from plasmid pCY20, was co-expressed with the Ll.LtrB group II intron (red line) flanked with small exons (brown and orange boxes) from
plasmid pLNRK (camR) (Intron+). Co-expression of the mRNA with an intron-less allele was used as the control (Intron-). This system was used in assays
shown in panels C-D. Splicing of the intron-containing pre-mRNA generates small mRNA (smRNA) and Intron, and the latter is proposed to interact
with the mRNA via EBS and IBS base pairing. To the right, mRNAs were analyzed by Northern blotting (top) as in Figure 1B, and LtrB relaxase protein
Figure 5 continued on next page
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Figure 5 continued
was analyzed by Western blotting as in Figure 1C (bottom). Representative data of three biological replicates is shown. Quantitation of mRNA (two
bands, bracketed) and protein levels are denoted at the bottom of the images. Dagger (>), unexpected product (identified in Figures 5 and 6 as RNA
3). (B) EBS–IBS interaction sequences. WT (wt) and mutated (m) Intron_EBS (red) and mRNA_ IBS (black) sequences are shown with Watson–Crick pairs
between them indicated as vertical bars and the wobble U:G pairs shown as a dot. Nucleotide substitutions in mutated EBS-IBS sequences are shown
in blue. (C) Effect of EBS mutation on mRNA levels. mRNAs (two bands, bracketed) were analyzed by Northern blotting (top) as in Figure 1B.
Quantitation of mRNA levels (derived from three biological replicates) is denoted at the bottom. Dagger (>), unexpected product (identified in
Figures 5 and 6 as RNA 3). (D) Effect of IBS mutation on mRNA levels. RNAs were analyzed by Northern blotting with a 50 -exon specific probe (black
bar). Quantitation of mRNA (two bands, bracketed) levels (derived from three biological replicates) is denoted at the bottom. Daggers (>), unexpected
products (identified in Figures 5 and 6 as RNA 1 and RNA 4).
DOI: https://doi.org/10.7554/eLife.34268.012
The following figure supplements are available for figure 5:
Figure supplement 1. Reduction of gene expression is independent of retrohoming.
DOI: https://doi.org/10.7554/eLife.34268.013
Figure supplement 2. Complementation with EBS-IBS mutants shows mRNA targeting.
DOI: https://doi.org/10.7554/eLife.34268.014

versus lane 2). However, they reappeared when the EBS from the intron was mutated to complement the IBS within the relaxase mRNA in this mutant (Figure 7, lanes 6). This result confirmed that
all of the identified mRNA retargeting reactions rely on the intron-mRNA interaction that is based
on EBS-IBS base pairing.

Discussion
Group II introns are inherent inhibitors of gene expression
Inspired by the recently determined group II intron RNP structure and by the distribution features of
group II introns in bacterial genomes, we performed a comparative expression study of intron-containing and intron-less variants of otherwise identical genes, to investigate the impact of group II
introns on host gene expression. We discovered that group II introns reduce gene expression by
robustly decreasing the spliced mRNA level in bacteria (Figure 1). This group II intron-induced
mRNA disappearance appears independent of plasmids and promoters from which the genes are
expressed (Figure 2), and is independent of stresses and changes of environmental conditions (data
not shown). While this intron-induced reduction of mRNA levels was revealed mainly for the welldefined group IIA intron Ll.LtrB and its host ltrB relaxase gene in its native bacterial host Lactococcus
lactis, it was also shown for two other types of bacterial group II introns, the group IIB EcI5 and
group IIC BhI1 introns (Figure 2). Using the Ll.LtrB intron as the model, we also demonstrated that
this mRNA reduction results from interaction between the intron with its spliced mRNA, via EBS-IBS
base pairing (Figures 4, 5 and 7). Since ltrB is part of an operon containing also ltrC, ltrD, ltrE and
ltrF (Chen et al., 2005), it will be interesting to determine how ltrB targeting by the group II intron
affects levels of the entire transcript.
Interestingly, group II introns can also cause gene silencing in eukaryotic cells
(Chalamcharla et al., 2010; Zerbato et al., 2013). Here, EBS-IBS-based intron-mRNA interactions
shut down nuclear gene expression (Qu et al., 2014). Taken together, we conclude that group II
introns are inherent and general inhibitors of gene expression.

How the mRNA level is controlled by the intron
By using the in trans system, we revealed that through RNA-RNA interactions, the spliced intron can
retarget the mRNA in the cell (Figures 6–7, Figure 6—figure supplement 1 and 2). The intron’s
ribozyme activities include reverse splicing into the spliced mRNA, and the SER reaction. Because
forward splicing is usually favored in the cell, based on the high splicing efficiency shown in
Figure 1B, Figure 1—figure supplements 1–2, we speculate that reverse splicing accounts for a relatively small portion of mRNA loss. Additionally, a robust SER, which was also revealed in the in cis
system (Figure 6C), splits the 50 -exon from the mRNA, and the free 30 -exon appears to be degraded
(Figure 8A).
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Figure 6 continued on next page
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Figure 6 continued
probe (black bar), and compared to RNAs expressed in cis (left two lanes). This assay revealed both the predicted reverse splicing product (RNA 1), and
an additional RNA product (RNA 2) resulting from the reaction shown in (B). (B) RNA recombination. Left: At the second step of reverse splicing, 50 exons from the ltrB relaxase mRNA or the smRNA exchange with each other, thus producing chimeric intron precursors. These products could undergo
forward splicing, thereby producing chimeric mRNAs. Right: RNAs expressed with the in trans system (right two lanes) were detected using a probe
specific for the 30 -exon (black bar), and compared to RNAs expressed in cis (left two lanes). The mRNA was revealed as two bands (bracketed). This
assay revealed both of the two predicted products resulting from RNA recombination (RNA 2, RNA 3), and also the RNA 1 product described in (A). (C)
Spliced exons reopening (SER). Left: Either the relaxase mRNA or smRNA could be split by the intron at the exon-exon junction, thus freeing the 50 and 30 -exons. Right: RNAs expressed with the in trans system (right two lanes) were detected using the probe specific for the 50 -exon (black bar), and
compared to RNAs expressed in cis (left two lanes). The mRNA was revealed as two bands (bracketed). This assay revealed the predicted free 50 -exon
of the relaxase mRNA (RNA 4) resulting from SER in both the in trans and in cis systems, and also the RNA 1 product described in (A).
DOI: https://doi.org/10.7554/eLife.34268.015
The following figure supplements are available for figure 6:
Figure supplement 1. Characterization of mRNA retargeting reactions.
DOI: https://doi.org/10.7554/eLife.34268.016
Figure supplement 2. Identification of mRNA targeting products 1–4 by 5’ and 3’ RACE.
DOI: https://doi.org/10.7554/eLife.34268.017

Although group II introns commonly invade DNA sequences, targeting RNA in vivo has not been
previously described. However, RNP invasion of DNA is a relatively unfavorable event
(Aizawa et al., 2003), which makes it tempting to speculate that the RNA SER and subsequent RNA
degradation may favor DNA invasion and retromobility.
The RNA decay study with rifampicin indicated slower mRNA degradation in the Int+ cell (Figure 1—figure supplement 3). However, this result may be misleading as the residual RNA that
escapes intron targeting may be a more stable fraction. Alternatively, the intron may act as ribosomes do on bacterial mRNA, providing a ‘protective barrier’ by binding the mRNA that escapes
degradative attack by the group II intron (Deana and Belasco, 2005). Additionally, enhanced stability may be a reflection of the reciprocal relationship between the stability and concentration of bacterial mRNAs (Nouaille et al., 2017), such that lower mRNA levels in the Int+ cell, would lead to
higher stability of the mRNA. Whichever mechanism underlies the phenomenon, the consequence is
that a fraction of the mRNA is maintained for translation.

Implications for distribution and spread of group II introns
The discovery that group II introns inhibit gene expression likely explains why they are located
mostly outside of genes or in non-essential genes, and why they are maintained at low frequency in
bacterial genomes (Dai and Zimmerly, 2002a; Zimmerly and Semper, 2015). Group II intron-promoted reduction of gene expression could be the major driver that selected for group II introns
residing in intergenic or non-essential regions. It is therefore intriguing that there are rare cases of
essential genes containing group II introns in bacterial genomes (Candales et al., 2012; Dai et al.,
2003; Dai and Zimmerly, 2002a; Zimmerly and Semper, 2015). We speculate that, in these cases,
either robust gene expression is not needed, that reduction in gene expression is modest or that the
intron plays a regulatory role (Belfort, 2017). The effect of organellar group II introns that are commonly present in essential genes is largely unknown (Dai and Zimmerly, 2002a; Zimmerly and Semper, 2015). Perhaps many of these introns have lost the ability to target mRNA and cause its loss, or
do so very inefficiently. Alternatively, a lower expression level might be required for proper functions
of these host genes. Notably, favoring the latter notion, a recent study showed that the presence of
self-splicing introns including group II introns in the mitochondrion of Saccharomyces cerevisiae was
required for inefficient expression of host genes that was essential for maintaining proper mitochondrial function (Rudan et al., 2018).
Group II introns are also frequently found in mobile DNAs (Candales et al., 2012; Dai et al.,
2003; Dai and Zimmerly, 2002a; Zimmerly and Semper, 2015). One of the examples is the Ll.LtrB
group II intron that naturally resides in the conjugative plasmid pRS01, interrupting the ltrB relaxase
gene whose expression is required for the horizontal gene transfer (HGT) of the plasmid. A recent
study indicated that pRS01 promotes retromobility of the intron by providing LtrB relaxase that stimulates both the frequency and diversity of retrotransposition (RTP) events with its off-target DNA
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Figure 7. mRNA retargeting requires EBS-IBS interaction. RNAs expressed using the in trans system (Figure 5A), with both wild-type mRNA (lanes 1–3)
or the mRNA_IBS mutants (m*, lanes 4–6), in the presence or absence of the wild-type intron (+/-) or the intron_EBS mutant (m*), were analyzed by
Northern blotting as in Figure 6 and Figure 6—figure supplement 1 and representative results of three biological replicates are shown. The mRNA
retargeting products (RNAs 1–4, and RNAs 1 and 2 denoted with a black circle or square, respectively) indicated on the left, appear with the wild-type
mRNA (two bands, bracketed) in the presence of the wild-type intron. RNA signals revealed by intron-specific probing (middle panel) are boxed and
denoted with ‘?’ as their identities are unknown, because they were absent in the 50 - and 30 -exon specific probing (left and right panels). RNAs 1–4 are
absent in the mutants Intron_EBSm* (lanes 3) and mRNA_IBSm* (lanes 5) where EBS-IBS pairing cannot form. Notably, these bands appear when the
two mutants can complement each other by EBS-IBS pairing (lanes 6).
DOI: https://doi.org/10.7554/eLife.34268.018

nicking activity (Novikova et al., 2014). Here our study showed that the Ll.LtrB group II intron
reduces the conjugal transfer of pRS01 via inhibition of its host gene expression (Figure 3). Thus,
these findings together suggest that the two mobile genetic elements (MGEs) functionally interact
by exploiting ltrB relaxase gene expression. Whereas relaxase expression stimulates intron RTP and
HGT of the conjugative element, inhibition of relaxase expression by the group II intron opposes the
promotion of RTP and HGT (Figure 8B), effects that are likely in equilibrium. In general, expression
of conjugative transfer genes is tightly controlled to minimize the burden on the host (Zatyka and
Thomas, 1998). Indeed conjugative plasmid gene expression is kept in a default ‘off’ state and is
switched on only under conditions that are optimal for transfer of the conjugative element
(Singh and Meijer, 2014). Silencing of the relaxase gene by its resident group II intron therefore
represents a novel way in which a conjugative element is down-regulated.

Evolutionary implications
The demonstration that intron RNAs are not only able to transpose and cleave exogenous RNAs,
but can also recombine RNAs from different sources, suggests that progenitors of group II introns
could have processed RNAs in primitive genomes. These actions could have contributed to the generation of an evolved genome and a cell that has novel functions and evolutionary advantages.
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processes: splicing, reverse splicing, and spliced exons reopening (SER). While all these reactions could affect
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effects and equilibrium between pairs of reversible processes, a fraction of mRNA can be maintained for
translation. (B) Functional interactions of the Ll.LtrB group II intron with the conjugative plasmid pRS01 through the
intron host gene ltrB relaxase. Stimulation of retrotransposition by relaxase (green line), has been previously
Figure 8 continued on next page
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Figure 8 continued
reported (Novikova et al., 2014). Reduced expression of ltrB relaxase by the intron (blue line) and its resulting
reduction in pRS01conjugtaion (dashed blue line) as revealed in this study are shown.
DOI: https://doi.org/10.7554/eLife.34268.019

In regard to the ancestral relationship between group II and spliceosomal introns, expression of
group II introns in nuclei causes gene silencing in eukaryotic cells (Chalamcharla et al., 2010;
Zerbato et al., 2013). In this study, we demonstrated that group II introns also hinder gene expression in bacteria. Notably, a common mechanism underlying the group II intron-promoted inhibition
of gene expression in bacteria and eukaryotes is based on interactions between intron and mRNA
via EBS-IBS base pairing (Qu et al., 2014). In contrast to group II introns, many spliceosomal introns
are shown to enhance gene expression in plants and other organisms (Le Hir et al., 2003;
Rose, 2008). Interactions between the intron and mRNA no longer exist in the splicing of spliceosomal introns, where such pairings have been functionally substituted with interactions between U5
snRNA and mRNA (Hang et al., 2015; Qu et al., 2016; Yan et al., 2015). We speculate that,
through these changes, introns can promote mRNA levels and gene expression, or at very least not
be inhibitory, and therefore provided a force that could have stimulated evolution of group II introns
into spliceosomal introns in primitive nuclear genomes.

Materials and methods
Key resources table
Reagent type (species)
or resource

Designation

Source or reference

Identifiers

Strain, strain
background (Lactococcus lactis)

IL1403

PMID: 11337471

Strain, strain
background (Lactococcus lactis)

IL1403 (FA-R)

Belfort Lab

Strain, strain
background (Escherichia coli)

MC1061

PMID:6997493

Antibody

LtrB antibody

Gary Dunny,
personal communication

Commercial assay or kit

QuikChange Lightning
Site-Directed Mutagenesis Kit

Agilent, Santa Clara, CA

210519

Commercial assay or kit

iScript cDNA Synthesis Kit

Bio-Rad, Hercules, CA

1708890

Commercial assay or kit

iTaq Universal SYBR
Green Supermix

Bio-Rad

172–5120

Commercial assay or kit

5’ RACE System

Invitrogen, Carlsbad, CA

18374058

Commercial assay or kit

3’ RACE System

Invitrogen

18373019

Commercial assay or kit

SMARTer RACE 5’/3’ kit

Takara, Mountain View, CA

634860

Additional
information

Fusidic Acid
Resistant

Strains and growth conditions
Lactococcus lactis IL1403 was used for ltrB gene expression and RNA and protein analysis. IL1403
pRS01 ltrB- (DLtrB::tet) and IL1403 (FAR) were used as donor and recipient strains for conjugation,
respectively. Cultures were grown in M17 media supplemented with 0.5% glucose (GM17) in tightlycapped tubes or bottles at 30˚C without shaking. For gene expression, cultures were grown to
OD600 ~0.6 and nisin was added to a final concentration of 0.4 mg/ml, for 2–3 hr. Cultures were spun
at 5000 x g and pellets were stored at 80˚C. Where appropriate, the media contained spectinomycin (Spec) at 300 mg/ml, chloramphenicol (Cam) at 10 mg/ml, erythromycin (Erm) at 10 mg/ml, or fusidic acid (FA) at 25 mg/ml.
Escherichia coli MC1061(DE3) was used for over-expression of EcI5 and BhI1 plasmids. Cultures
were grown in LB media with 100 mg/ml ampicillin at 37˚C with aeration. At OD600 ~0.3, cultures
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were induced with 0.1 mM IPTG for 3 hr. Cultures were spun at 5000 x g and pellets were stored at
80˚C.

Plasmids
All plasmids created or used are listed in Supplementary file 1, and DNA oligonucleotides used in
this study are listed in Supplementary file 1. Plasmids pCY20LtrB (Int-) and pCY20LtrB::Ll.LtrB (Int+)
were the vector pair used in the intron in cis system for comparative analysis of ltrB relaxase gene
expression in the absence and presence of the Ll.LtrB intron. With the in trans system, pCY20LtrB
was used for ltrB relaxase gene expression while plasmid pLNRK smEx::Ll.LtrB was used to express
the intron. For an intron-less control in this system, pLNRK smEx::Ll.LtrB was replaced with plasmid
pLNRK smEx, that contained only the small flanking exons. The ltrB IBS mutants, mRNA_IBSm and
mRNA_IBSm*, and Ll.LtrB intron mutants including EBSm, EBSm* and Triad, and the IEP EN and RT
mutants were created with the above pCY20 and pLNRK plasmids by site-directed mutagenesis
(SDM) using QuickChange Lightning kit (Agilent, Santa Clara, CA). More specifically, to create
EBSm*, the IBS region of the small exons of EBSm were mutated to make the intron splicing competent. This was done with 2 rounds of SDM PCR, using the plasmid product from PCR1 as the template for PCR2. All plasmids were confirmed by sequencing (see oligonucleotides used in
Supplementary file 1). Construction of other plasmids used in this study are detailed below.

pDL278 and pAMJ328 expression plasmids
For cloning of pDL278 (LeBlanc et al., 1992) and pAMJ328 (Jørgensen et al., 2014) constructs, ltrB
-/+Ll.LtrB intron inserts were PCR amplified from pCY20 plasmids using primers with SphI and
BamHI sites (IDT4767 and 4768, respectively) for pDL278, or primers with SpeI and PstI sites
(IDT4766 and 4769, respectively) for pAMJ328. The PCR products were first cloned into pGEM-T
(Promega, Fitchburg, WI) as per manufacturer’s protocol and then cut and pasted into respective
parental plasmids.

EcI5 and BhI1 expression plasmids
HS-GFP cloning: Homing site (HS) sequence of EcI5 or BhI1 was fused with GFP coding sequence
directly by PCR of plasmid pFA6a-GFP(S65T)-KanMx6 (Addgene, Cambridge, MA) using primer
pairs IDT4831/4827 and IDT4826/4827 respectively, and with HindIII and SpeI restriction sites
inserted respectively in the 50 - and 30 -termini of the amplicons. GPII-GFP cloning: EcI5 or BhI1 group
II intron full-length sequences was amplified by PCR of genomic DNAs provided by Dr. Alan Lambowitz using primer pairs IDT4832/4833 and IDT4828/4829 respectively, and with HindIII restriction
site inserted in the 50 -terminus of the amplicons. GFP coding sequence was amplified by PCR of
plasmid pFA6a-GFP(S65T)-KanMx6 (Addgene) using primer pairs IDT4834/4827 or IDT4830/4827 for
SOEing of GFP with ECI5 or BhI1 introns. The GFP amplicon was then mixed and ligated with the
respective EcI5 or BhI1 amplicons by PCR using primer pairs IDT4832/4827 and IDT4828/4827
respectively, and with HindIII and SpeI restriction sites inserted respectively in the 50 -and 30 -termini
of the amplicons. pET11a plasmid was digested with NdeI and BamHI and ligated with pre-annealed
DNA oligonucleotides IDT4824 and IDT4825 that contain HindIII and SpeI sites. The plasmid was
digested with HindIII and SpeI, and ligated with digested EcI5 or BhI1 HS-GFP or GPII-GFP resulting
in the plasmids pET11a-HS-GFP and pET11a-GPII-GFP.

Plasmids for RNA pull-down
Streptavidin aptamer-containing Ll.LtrB intron was amplified from plasmid pGpII(SA)-CUP1(6XMS2)
by PCR using primer pairs IDT4942/4943, digested with XhoI and NotI and ligated into digested
plasmid pLNRK smEx-nLIC (Qu et al., 2014). The resulting plasmid, pLNRK smEx::Ll.LtrB DORF (SA)nLIC, was used for expression of SA aptamer-containing intron. The same plasmid backbone was
ligated with pre-annealed DNA oligonucleotides IDT5051 and IDT5052 that contain XhoI and NotI
sites, resulting in the control plasmid, pLNRK smEx::Ll.LtrB DORF-nLIC.

Northern blotting
For RNA analysis, 7.5 mg of total RNA was separated on a 1.2% agarose/formaldehyde gel and transferred to hybond XL membrane (GE Healthcare, Pittsburgh, PA), which was then UV cross-linked and
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probed with 32P-labeled oligonucleotides using Rapid-hyb buffer (GE Healthcare). For the Ll.LtrB
intron, the membranes were hybridized for detection of mRNA exon splice junction (IDT4685), 50 Exon (IDT5374), 30 -Exon (IDT5012), and Ll.LtrB intron (IDT1073). For the EcI5 intron, membranes
were hybridized for the detection of mRNA (IDT4972) and intron (IDT4970), and for BhI1 intron,
membranes were hybridized for mRNA (IDT4975) and intron (IDT4973). All membranes were probed
for 16S rRNA (IDT861) as a loading control. Images were exposed on a phosphor screen, scanned
on a Typhoon Trio, and quantified using ImageQuant.

Western blotting
For LtrB relaxase analysis, total cell lysate was separated on a 12% SDS-polyacrylamide gel and
transferred to 0.2 mM Immuno-blot PVDF membrane (Bio-Rad) at 25V for 30 min. The membrane
was blocked with 5% dry milk in TBS-T (20 mM Tris, 140 mM NaCl, 2% Tween), incubated with a 1/
1500 dilution of primary anti-relaxase antibody for 1 hr, washed with TBS-T twice for 15 min, and
incubated with a 1/10,000 dilution of secondary HRP-labeled anti-rabbit antibody (Advansta, Menlo
Park, CA) for 1 hr. Chemiluminescent HRP substrate (Advansta WesternBright ECL) was used for
detection. For lane normalization, total protein was visualized from a coomassie stained 12% SDSpolyacrylamide gel. All images were scanned using a Bio-Rad ChemiDoc MP. Relaxase bands and
total protein were quantified using Bio-Rad Image Lab software.

qRT-PCR
cDNA synthesis was performed in a 20 ml reaction with 10 ng of DNase treated (Promega RQ1
DNase) RNA template using iScript (Bio-Rad, Hercules, CA), as per manufacturer’s protocol. Minus
RT (RT-) controls were also performed. Total RNA quality and primer specificity were analyzed by gel
electrophoresis prior to qPCR. qPCR reactions were done in a total volume of 10 ml, using iTaq Universal SYBR Green Supermix (Bio-Rad) and contained 2 ml of the cDNA reaction as template and 5
pmol of each primer. Reactions were run in technical triplicates and a no-template control was
included in every run. Reactions were amplified with the following conditions: 95˚C for 30 s, (95˚C
for 5 s, 60˚C for 10 s) x 40 cycles, melt curve 65˚C to 95˚C (0.5˚C every 2 s), on a Bio-Rad CFX384
Touch Real-Time PCR Detection System. Three biological replicates were run for each sample.
Amplification efficiencies (E) of all primers were calculated using a 10-fold dilution and standard
curve. Efficiencies, Ct values and charts were obtained using Bio-Rad CFX Manager Software. Primers used, their percent amplification efficiencies and amplicon lengths are listed in
Supplementary file 1. Relative gene expression of each target (tar) was normalized to a reference
gene (ref), CopA, whose expression was demonstrated to be constant in a previous study
(Magnani et al., 2008), and calculated using the following equation, with subtraction of RTbackground:
½ðEtar Þ

Ctðmean;RTþÞ

ðEtar Þ

Ctðmean;RT Þ

=½ðEref Þ

Ctðmean;RTþÞ

ðEref Þ

Ctðmean;RT Þ

:

Reverse transcription primer extension
To identify splicing products, primer extension was performed using SuperScript III Reverse Transcriptase (Thermo Fisher Scientific, Waltham, MA), as per manufacturer’s protocol, with 4 mg of
DNase-treated RNA and 0.4 pmol of 32P-labeled oligonucleotides. Oligonucleotide IDT4836 was
used with the addition of ddTTP for detection of intron precursor and spliced intron. Products were
separated on an 8% Urea-polyacrylamide sequencing gel. To measure 50 -end transcription levels of
the mRNA and intron precursor, IDT4916 was used, and products were separated on a 10% Ureapolyacrylamide gel. To analyze RNAs that were pulled down with streptavidin resin, IDT5078,
IDT1073 and IDT5127 were used to probe the smRNAs, intron RNAs, and 6S non-coding RNA,
respectively. To measure splicing efficiency of the intron_EBSm* mutant, oligonucleotide IDT1073
was used to detect the presence of intron precursor and spliced intron, and products were separated on a 10% Urea-polyacrylamide gel. Images were exposed on a phosphor screen, scanned on a
Typhoon Trio, and quantified using ImageQuant.

mRNA degradation
L. lactis IL1403 was grown to OD600 ~0.6 and nisin was added to a final concentration of 0.4 mg/ml
for 0.5 hr. Rifampicin was then added to a final concentration of 0.2 mg/ml, and 10 ml of culture was
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removed for each aliquot and immediately spun down at 4˚C. Total RNA was prepared and analyzed
for Northern blots.

Polysome profiling
To perform polysome profiling, 200 ml of L. lactis IL1403 Int+/Int- cells (1:20 dilution of saturated
overnight culture) were grown and induced for gene expression with nisin for 2–3 hr. 100 mg/ml
chloramphenicol was added and the cultures were chilled on ice for ~30 min with intermittent whirling and then collected by centrifugation at 5,000 rpm for 10 min at 4˚C. Cell pellets were resuspended in 500 ml of ice-cold lysis buffer (20 mM Tris-HCl, pH 8.0; 140 mM KCl; 40 mM MgCl2; 0.5
mM DTT; 100 mg/ml chloramphenicol; 1 mg/ml heparin; 20 mM EGTA; 1% Triton X-100) and washed
twice with the same buffer. The cell pellets were resuspended again in 500 ml of lysis buffer and
snap-frozen in liquid nitrogen. Then the cells were disrupted at 4˚C in 15 ml falcon tubes with 500 ml
of 0.1 mm ice-cold glass beads by rigorous vortexing (30 s for 20 times, with 1 min interval) and then
briefly spun down at 4,000 rpm for 5 min. Crude cell lysate was then gently mixed, transferred into
1.5 ml tubes on ice, and cleared by 14,000 rpm for 25 min at 4˚C. 400 ml of the cleared lysates were
then loaded onto prepared 10–50% sucrose gradients in lysis buffer without 0.5 mg/ml heparin and
centrifuged at 36,000 rpm for 153 min at 4˚C (SW41 rotor). 30 fractions of ~400 ml each were collected for each gradient from top to bottom. RNAs were extracted from each fraction by using phenol/chloroform and analyzed by running gels and performing Northern blotting.

Conjugation assays
To measure conjugation efficiencies, L. lactis IL1403 (FAR) was used as the recipient strain and was
grown to an OD600 ~0.6 and then for an additional 3 hr. L. lactis IL1403 DLtrB::tet (ermR) was used as
the donor strain, and contained either the Int- plasmid pCY20LtrB, or the Int+ plasmid pCY20LtrB::Ll.
LtrB. Cultures were grown to OD600 ~0.6 and nisin was added to a final concentration of 0.4 mg/ml
for 3 hr. Equal volume of donor and recipient were mixed, spotted on pre-incubated filters (0.45 mm
pore size, Millipore) on GM17 plates, and incubated ~18 hr at 30˚C. The filters were removed from
the plates, washed with 5 ml GM17 in a 50 ml conical tube by vortexing, and the wash was spotted
or plated on GM17 plus 25 mg/ml fusidic acid and 10 mg/ml erythromycin for selection of transconjugants. Plates were incubated ~18 hr at 30˚C. To calculate input donor, the donor strain was diluted
to 10 6 and spotted or plated on GM17 plus 10 mg/ml erythromycin. Conjugation frequency was
expressed as exconjugants per donor (ErmRFAR/ErmR).

RNA Pull-down
Bacterial cells (100 ml) were collected after 2–3 hr of nisin induction of RNA expression and disrupted in 800 ml of CB500 solution (20 mM Tris–HCl, pH 8.0, 500 mM NaCl, 0.1 mM EDTA, 1 mM
PMSF) by vortexing (30 s, rest for 1 min, 24 cycles) using 500 ml of 0.1 mm ice-cold glass beads
(Sigma). Lysates were cleared by centrifugation at 14,000 rpm for 25 min. To pull down RNAs, ~500
ml of cleared lysate was incubated with 100 ml of streptavidin resin (Thermo Scientific) that was equilibrated with CB500. The resin was washed eight times with 1 ml CB500 buffer. RNAs bound to resin
were eluted with 400 ml of 5 mM biotin for 1 hr and were extracted from the eluates. RNA identities
were determined by using reverse transcription primer extensions.

50 and 30 RACE
To further identify mRNA targeting products 1–4, 5’ and 3’ RACE (Rapid Amplification of cDNA
Ends) experiments were performed. Briefly, Int+ and Int- strains from cis and trans systems were
grown and induced as previously described, and total RNA was prepared. RNAs were polyA-tailed
using E. coli Poly(A) Polymerase (New England BioLabs, Ipswich, MA). 5’ and 3’ RACE experiments
were then done using Invitrogen 5’ or 3’ RACE kits (Cat# 18374058 or 18373019), or the Takara
SMARTer 5’/3’ kit (Cat# 634859), following the kit protocols. Reverse transcriptase was used to synthesize cDNAs, which were then used as template for PCR amplification using GSP (gene specific primers IDT6074 and IDT6070 to ltrB 5’ or 3’ exon, respectively) along with a kit universal primer
annealing to the synthesized cDNA. 5’ and 3’ RACE PCR products were run out on a 1.2% agarose
gel, and the bands were excised, gel purified, and sequenced directly (Eton Bioscience, San Diego,
CA) or cloned into pGEM-T vector (Promega), and then sequenced, to confirm their identity.
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mitochondrial function in Saccharomyces cerevisiae has become dependent on inefficient splicing. eLife 7:
e35330. DOI: https://doi.org/10.7554/eLife.35330, PMID: 29570052
Schoenberg DR. 2007. The end defines the means in bacterial mRNA decay. Nature Chemical Biology 3:535–
536. DOI: https://doi.org/10.1038/nchembio0907-535, PMID: 17710097
Singh PK, Meijer WJ. 2014. Diverse regulatory circuits for transfer of conjugative elements. FEMS Microbiology
Letters 358:119–128. DOI: https://doi.org/10.1111/1574-6968.12526, PMID: 24995588
Toor N, Keating KS, Taylor SD, Pyle AM. 2008. Crystal structure of a self-spliced group II intron. Science 320:77–
82. DOI: https://doi.org/10.1126/science.1153803, PMID: 18388288
Toro N, Martı́nez-Abarca F. 2013. Comprehensive phylogenetic analysis of bacterial group II intron-encoded
ORFs lacking the DNA endonuclease domain reveals new varieties. PLoS One 8:e55102. DOI: https://doi.org/
10.1371/journal.pone.0055102, PMID: 23355907
Truong DM, Hewitt FC, Hanson JH, Cui X, Lambowitz AM. 2015. Retrohoming of a mobile group II intron in
human cells suggests how eukaryotes limit group II intron proliferation. PLOS Genetics 11:e1005422.
DOI: https://doi.org/10.1371/journal.pgen.1005422, PMID: 26241656
Wank H, SanFilippo J, Singh RN, Matsuura M, Lambowitz AM. 1999. A reverse transcriptase/maturase promotes
splicing by binding at its own coding segment in a group II intron RNA. Molecular Cell 4:239–250. DOI: https://
doi.org/10.1016/S1097-2765(00)80371-8, PMID: 10488339
Yan C, Hang J, Wan R, Huang M, Wong CC, Shi Y. 2015. Structure of a yeast spliceosome at 3.6-angstrom
resolution. Science 349:1182–1191. DOI: https://doi.org/10.1126/science.aac7629, PMID: 26292707
Zatyka M, Thomas CM. 1998. Control of genes for conjugative transfer of plasmids and other mobile elements.
FEMS Microbiology Reviews 21:291–319. DOI: https://doi.org/10.1111/j.1574-6976.1998.tb00355.x, PMID: 254
81925
Zerbato M, Holic N, Moniot-Frin S, Ingrao D, Galy A, Perea J. 2013. The brown algae Pl.LSU/2 group II intronencoded protein has functional reverse transcriptase and maturase activities. PLoS One 8:e58263. DOI: https://
doi.org/10.1371/journal.pone.0058263, PMID: 23505475
Zimmerly S, Guo H, Perlman PS, Lambowitz AM. 1995. Group II intron mobility occurs by target DNA-primed
reverse transcription. Cell 82:545–554. DOI: https://doi.org/10.1016/0092-8674(95)90027-6, PMID: 7664334
Zimmerly S, Semper C. 2015. Evolution of group II introns. Mobile DNA 6:7. DOI: https://doi.org/10.1186/
s13100-015-0037-5, PMID: 25960782

Qu et al. eLife 2018;7:e34268. DOI: https://doi.org/10.7554/eLife.34268

23 of 23

